Ibotta, Inc.
NYSE:IBTASoftware - Application
-$0.19 today
- Market cap
- $1.16B
- Beta
- -0.58
- P/E (TTM)
- -96.1
- EPS (TTM)
- -$0.30
Volume 0.45M
Average 0.22M
IBTA EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Ibotta, Inc.NYSE: IBTA
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) turns negative
Q1 FY2026 EPS (Diluted) was -$0.43, compared with $0.02 a year earlier. Trailing-twelve-month EPS (Diluted) was -$0.34.
Context
- EPS (Diluted) increased in 2 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 3 analysts of -$0.67 (-661.6%) for the fiscal year ending Dec 2026, a slowdown from the -95.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.43-1025.7% QoQ
- Last fiscal yearDec 2025
- $0.12-95.3% YoY
- LTMMar 2026
- -$0.34-122.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -2674.9% | -356.7% | +2318.1 pp |
| 1 year | -95.3% | -661.6% | -566.3 pp |
| 3-year CAGR | — | +10.6% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 0.12 USD
- Year-over-year change
- -95.3%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.12 | -95.3% |
| FY2024 | 2024-12-31 | 2.56 | +103.2% |
| FY2023 | 2023-12-31 | 1.26 | +169.6% |
| FY2022 | 2022-12-31 | (1.81) | — |
EPS (Diluted) vs competitors
How IBTA compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
- Its year-over-year change of -122.8% is the 9th highest of 10, against a peer median of +60.4%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | CN¥1.67 CNY | +206.6% | +119.2% | |
| LTM Mar 2026 | $1.25 USD | +420.5% | +169.8% | |
| LTM Mar 2026 | $1.18 USD | +60.4% | +86.6% | |
| LTM Mar 2026 | $0.97 USD | +708.3% | +175.1% | |
| LTM Mar 2026 | $0.13 USD | +60.0% | — | |
| LTM Mar 2026 | -$0.1 USD | +54.0% | — | |
| LTM Mar 2026 | -$0.12 USD | +47.6% | — | |
| LTM Mar 2026 | -$0.33 USD | +63.2% | — | |
| LTM Mar 2026 | -$0.34 USD | -122.8% | — | |
| LTM Mar 2026 | -$1.26 USD | -171.1% | — | |
| Peer median (excluding IBTA) | — | +60.4% | +144.5% | |
Competitors are the stored peer set for IBTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 210.7M | 320.04M | 367.25M | 342.39M |
| Cost of Revenue | 49.22M | 47.65M | 50.12M | 74.97M |
| Gross Profit | 161.48M | 272.38M | 317.13M | 267.42M |
| Gross Margin | 76.6% | 85.1% | 86.4% | 78.1% |
| Research & Development | 42.56M | 50M | 63.27M | 61.08M |
| Selling, General & Admin | 159.23M | 166.39M | 221.95M | 207.18M |
| Operating Expenses | 201.79M | 216.39M | 289.21M | 265.77M |
| Depreciation & Amortization | 6.32M | 6.66M | 8.08M | 8.32M |
| EBITDA | (42.97M) | 57.6M | 32.58M | 18.17M |
| EBITDA Margin | -20.4% | 18.0% | 8.9% | 5.3% |
| Operating Income | (40.31M) | 56M | 27.93M | 1.66M |
| Operating Margin | -19.1% | 17.5% | 7.6% | 0.5% |
| Interest Income | 0 | 0 | 9.41M | 10.78M |
| Interest Expense | 5.31M | 6.88M | 0 | 0 |
| Other Income / Expenses | (14.29M) | (11.95M) | (3.43M) | 8.19M |
| Income Before Tax | (54.6M) | 44.05M | 24.5M | 9.85M |
| Pre-Tax Margin | -25.9% | 13.8% | 6.7% | 2.9% |
| Income Tax Expense | 262K | 5.93M | (44.25M) | 6.27M |
| Net Income | (54.86M) | 38.12M | 68.74M | 3.58M |
| Net Margin | -26.0% | 11.9% | 18.7% | 1.0% |
| EPS (Basic) | (1.81) | 1.26 | 2.85 | 0.13 |
| EPS (Diluted) | (1.81) | 1.26 | 2.56 | 0.12 |
| Weighted Avg Shares | 30.24M | 30.24M | 24.12M | 28.37M |
| Weighted Avg Shares (Diluted) | 30.24M | 30.24M | 26.86M | 30.1M |
Ibotta, Inc.
NYSE:IBTA
Intrinsic Alpha fair value
Locked
Current Price
$56.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.